Drug Shortage Report for RABEPRAZOLE EC

Last updated on 2024-10-01 History
Report ID 214284
Drug Identification Number 02356511
Brand name RABEPRAZOLE EC
Common or Proper name RABEPRAZOLE SODIUM
Company Name SANIS HEALTH INC
Market Status MARKETED
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 10MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-12-22
Estimated end date 2024-10-04
Actual end date 2024-09-30
Shortage status Resolved
Updated date 2024-10-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v32 2024-10-01 English Compare
v31 2024-09-30 French Compare
v30 2024-09-30 English Compare
v29 2024-09-30 English Compare
v28 2024-09-09 French Compare
v27 2024-09-09 English Compare
v26 2024-08-28 French Compare
v25 2024-08-28 English Compare
v24 2024-07-24 French Compare
v23 2024-07-24 English Compare
v22 2024-05-08 French Compare
v21 2024-05-08 English Compare
v20 2024-05-01 French Compare
v19 2024-05-01 English Compare
v18 2024-04-24 French Compare
v17 2024-04-24 English Compare
v16 2024-04-17 French Compare
v15 2024-04-17 English Compare
v14 2024-04-10 French Compare
v13 2024-04-10 English Compare

Showing 1 to 20 of 32